TURNSTONE BIOLOGICS CORP (TSBX) Stock Cash Flow
NASDAQ:TSBX - Nasdaq - US90042W1009 - Common Stock
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | |||||||
| Net Income | -74.42M | -55.20M | -30.83M | 33.27M | |||
| Depreciation Amortization | 2.16M | 2.80M | 3.90M | 1.39M | |||
| Income Taxes - Deferred | N/A | N/A | 0.00 | -101.00K | |||
| Change In Working Capital | 4.57M | -17.92M | -57.97M | -85.65M | |||
| Taxes Paid | 219.00K | 100.00K | N/A | N/A | |||
| Other non cash items | 1.24M | 4.17M | 13.84M | 5.47M | |||
| OPERATING CASH FLOW | -66.47M | -66.15M | -71.06M | -45.63M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | |||||||
| Capital Expenditure | -248.00K | -1.25M | -5.17M | -3.41M | |||
| Other Investing Activity | 52.23M | -26.84M | -9.76M | 58.00K | |||
| INVESTING CASH FLOW | 51.98M | -28.09M | -14.93M | -3.35M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | |||||||
| Stock Issued/Repurchased | -125.00K | 77.94M | 157.00K | 79.95M | |||
| Other Financing Activity | -33.00K | -898.00K | -2.81M | N/A | |||
| FINANCING CASH FLOW | -158.00K | 77.05M | -2.66M | 79.95M | |||
| CHANGE IN CASH | -14.64M | -17.20M | -88.65M | 30.98M | |||
| FREE CASH FLOW | |||||||
| Operating Cash Flow | -66.47M | -66.15M | -71.06M | -45.63M | |||
| Capital Expenditure | -248.00K | -1.25M | -5.17M | -3.41M | |||
| FREE CASH FLOW | -66.71M | -67.40M | -76.23M | -49.03M | |||
All data in USD